| Universe Pharmaceuticals INC |
UPC |
0% | 0% |
| Connect Biopharma Holdings Ltd. |
CNTB |
0% | -20% |
| Gain Therapeutics Inc. |
GANX |
-25% | 12% |
| Prometheus Biosciences Inc. |
RXDX |
0% | 0% |
| NexImmune Inc. |
NEXI |
0% | 0% |
| Adagene Inc. |
ADAG |
98% | 2% |
| Angion Biomedica Corp. |
ANGN |
0% | 0% |
| Bolt Biotherapeutics Inc. |
BOLT |
0% | 10% |
| Pharvaris B.V. |
PHVS |
55% | -4% |
| Terns Pharmaceuticals Inc. |
TERN |
819% | 4% |
| Vor Biopharma Inc. |
VOR |
0% | 20% |
| Landos Biopharma Inc. |
LABP |
0% | 0% |
| Sana Biotechnology Inc. |
SANA |
95% | 4% |
| Sensei Biotherapeutics Inc. |
SNSE |
0% | 3% |
| Gracell Biotechnologies Inc. |
GRCL |
0% | 0% |
| Virios Therapeutics LLC |
VIRI |
0% | 0% |
| AbCellera Biologics Inc. |
ABCL |
96% | 6% |
| Olema Pharmaceuticals Inc. |
OLMA |
115% | 1% |
| Atea Pharmaceuticals Inc. |
AVIR |
33% | 4% |
| Galecto Inc. |
GLTO |
0% | 0% |
|
|
|
|
| Foghorn Therapeutics Inc. |
FHTX |
-11% | 1% |
| Nkarta Inc. |
NKTX |
30% | 0% |
| Zomedica Pharmaceuticals Corp |
ZOM |
0% | 21% |
| Synthetic Biologics Inc |
SYN |
0% | 0% |
| Palatin Technologies Inc |
PTN |
0% | 26% |
| Oragenics Inc |
OGEN |
0% | 0% |
| NovaBay Pharmaceuticals Inc |
NBY |
0% | 0% |
| Matinas Biopharma Holdings Inc |
MTNB |
0% | 0% |
| iBio Inc |
IBIO |
0% | 0% |
| CorMedix Inc |
CRMD |
3% | 1% |
| China Pharma Holdings Inc |
CPHI |
0% | 0% |
| Can Fite Biopharma Ltd |
CANF |
0% | 0% |
| Ampio Pharmaceuticals Inc |
AMPE |
0% | 0% |
| Actinium Pharmaceuticals Inc |
ATNM |
-12% | 14% |
| Zoetis Inc |
ZTS |
-52% | 0% |
| Teva Pharmaceutical Industries Limited |
TEVA |
56% | -4% |
| Sanofi |
SNY |
-11% | -0% |
| Prestige Consumer Healthcare Inc |
PBH |
-40% | -2% |
| Pfizer Inc |
PFE |
-4% | 0% |
| Perrigo Company |
PRGO |
-56% | 1% |
|
|
|
|
| Novo Nordisk A S |
NVO |
-51% | 2% |
| Novartis AG |
NVS |
47% | 0% |
| Merck & Company Inc |
MRK |
16% | -0% |
| Lannett Co Inc |
LCI |
0% | 0% |
| Johnson & Johnson |
JNJ |
55% | -0% |
| GlaxoSmithKline PLC |
GSK |
53% | -1% |
| Emergent Biosolutions Inc |
EBS |
-18% | 8% |
| Eli Lilly and Company |
LLY |
38% | 1% |
| Dr Reddy`s Laboratories Ltd |
RDY |
-14% | -2% |
| Bristol Myers Squibb Company |
BMY |
-3% | -0% |
| Bausch Health Companies Inc |
BHC |
-31% | -3% |
| Astrazeneca PLC |
AZN |
0% | 1% |
| AbbVie Inc |
ABBV |
18% | 2% |
| Abbott Laboratories |
ABT |
-24% | 1% |
| Zealand Pharma A S |
ZEAL |
0% | 0% |
| XTL Biopharmaceuticals Ltd |
XTLB |
-78% | 9% |
| XOMA Corporation |
XOMA |
56% | 3% |
| Xenetic Biosciences Inc |
XBIO |
0% | 0% |
| Xencor Inc |
XNCR |
-51% | 5% |
| VistaGen Therapeutics Inc |
VTGN |
0% | 0% |
|
|
|
|
| Veru Inc |
VERU |
0% | 12% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
8% | 1% |
| Verona Pharma plc |
VRNA |
0% | 0% |
| Verastem Inc |
VSTM |
0% | 0% |
| United Therapeutics Corporation |
UTHR |
56% | 1% |
| Tyme Technologies Inc |
TYME |
0% | 0% |
| Tonix Pharmaceuticals Holding Corp |
TNXP |
0% | 0% |
| Tiziana Life Sciences plc |
TLSA |
87% | 4% |
| Theravance Biopharma Inc |
TBPH |
72% | -1% |
| TherapeuticsMD Inc |
TXMD |
38% | 87% |
| TG Therapeutics Inc |
TGTX |
25% | -0% |
| Supernus Pharmaceuticals Inc |
SUPN |
25% | 2% |
| Spectrum Pharmaceuticals Inc |
SPPI |
0% | 0% |
| Sonoma Pharmaceuticals Inc |
SNOA |
0% | 0% |
| Soligenix Inc |
SNGX |
0% | 0% |
| Sinovac Biotech Ltd |
SVA |
0% | 0% |
| SIGA Technologies Inc |
SIGA |
-30% | 5% |
| Sesen Bio Inc |
SESN |
0% | 0% |
| SELLAS Life Sciences Group Inc |
SLS |
780% | 2% |
| Savara Inc |
SVRA |
66% | 1% |
|
|
|
|
| Sarepta Therapeutics Inc |
SRPT |
-87% | 4% |
| Rocket Pharmaceuticals Inc |
RCKT |
-76% | -0% |
| Rigel Pharmaceuticals Inc |
RIGL |
0% | 0% |
| Reliv` International Inc |
RELV |
0% | 0% |
| Regulus Therapeutics Inc |
RGLS |
0% | 1% |
| Regeneron Pharmaceuticals Inc |
REGN |
-13% | 1% |
| Redhill Biopharma Ltd |
RDHL |
0% | 0% |
| Puma Biotechnology Inc |
PBYI |
141% | -3% |
| Pulmatrix Inc |
PULM |
-81% | 3% |
| PTC Therapeutics Inc |
PTCT |
59% | 3% |
| Prothena Corporation plc |
PRTA |
-28% | 0% |
| ProPhase Labs Inc |
PRPH |
0% | 7% |
| PLx Pharma Inc |
PLXP |
0% | 0% |
| Phio Pharmaceuticals Corp |
PHIO |
0% | 0% |
| Paratek Pharmaceuticals Inc |
PRTK |
0% | 0% |
| Pacira Pharmaceuticals Inc |
PCRX |
26% | -2% |
| Orgenesis Inc |
ORGS |
0% | 0% |
| Organogenesis Holdings Inc |
ORGO |
-17% | -3% |
| Oramed Pharmaceuticals Inc |
ORMP |
60% | 1% |
| Opko Health Inc |
OPK |
-3% | 0% |
|
|
|
|
| OncoSec Medical Incorporated |
ONCS |
0% | 0% |
| Onconova Therapeutics Inc |
ONTX |
0% | 0% |
| Oncolytics Biotech Inc |
ONCY |
-11% | 6% |
| Omeros Corporation |
OMER |
-1% | 13% |
| Neptune Wellness Solutions Inc |
NEPT |
0% | 0% |
| Nektar Therapeutics |
NKTR |
0% | 20% |
| Nature`s Sunshine Products Inc |
NATR |
43% | 0% |
| Mustang Bio Inc |
MBIO |
0% | 0% |
| Molecular Templates Inc |
MTEM |
0% | 0% |
| Mirati Therapeutics Inc |
MRTX |
0% | 0% |
| Midatech Pharma PLC |
MTP |
0% | 0% |
| Merrimack Pharmaceuticals Inc |
MACK |
0% | 0% |
| MEI Pharma Inc |
MEIP |
0% | 0% |
| MediciNova Inc |
MNOV |
-36% | 0% |
| Marker Therapeutics Inc |
MRKR |
0% | 0% |
| MannKind Corporation |
MNKD |
-46% | 1% |
| Madrigal Pharmaceuticals Inc |
MDGL |
50% | 4% |
| MacroGenics Inc |
MGNX |
20% | 6% |
| Lipocine Inc |
LPCN |
0% | 0% |
| Ligand Pharmaceuticals Incorporated |
LGND |
108% | 3% |
|
|
|
|
| Lifevantage Corporation |
LFVN |
-55% | 1% |
| Lexicon Pharmaceuticals Inc |
LXRX |
179% | 7% |
| LEAP THERAPEUTICS INC |
LPTX |
0% | 0% |
| Karyopharm Therapeutics Inc |
KPTI |
0% | 18% |
| Kamada Ltd |
KMDA |
19% | 7% |
| KalVista Pharmaceuticals Inc |
KALV |
198% | 6% |
| Jazz Pharmaceuticals plc |
JAZZ |
94% | -1% |
| Ironwood Pharmaceuticals Inc |
IRWD |
-20% | 2% |
| Ionis Pharmaceuticals Inc |
IONS |
110% | -0% |
| Intra Cellular Therapies Inc |
ITCI |
0% | 0% |
| Intercept Pharmaceuticals Inc |
ICPT |
0% | 0% |
| Insmed Inc |
INSM |
52% | 1% |
| Innoviva Inc |
INVA |
22% | 1% |
| Infinity Pharmaceuticals Inc |
INFI |
0% | 0% |
| IMV Inc |
IMV |
0% | 0% |
| Immutep Limited |
IMMP |
-82% | 1% |
| Immuron Limited |
IMRN |
-27% | 3% |
| ImmunoGen Inc |
IMGN |
0% | 0% |
| Horizon Pharma plc |
HZNP |
0% | 0% |
| Heron Therapeutics Inc |
HRTX |
-50% | 9% |
|
|
|
|
| Grifols S A |
GRFS |
-1% | 4% |
| Geron Corporation |
GERN |
-66% | 0% |
| Galectin Therapeutics Inc |
GALT |
122% | -11% |
| Fortress Biotech Inc |
FBIOP |
177% | 11% |
| Fortress Biotech Inc |
FBIO |
0% | 0% |
| Evoke Pharma Inc |
EVOK |
0% | 0% |
| Evofem Biosciences Inc |
EVFM |
0% | 0% |
| ESSA Pharma Inc |
EPIX |
0% | 4% |
| Esperion Therapeutics Inc |
ESPR |
43% | -1% |
| Epizyme Inc |
EPZM |
0% | 0% |
| Enochian Biosciences Inc |
ENOB |
0% | 10% |
| Endo International plc |
ENDP |
0% | 0% |
| Enanta Pharmaceuticals Inc |
ENTA |
136% | -3% |
| Dynavax Technologies Corporation |
DVAX |
0% | 1% |
| DURECT Corporation |
DRRX |
0% | 11% |
| Diffusion Pharmaceuticals Inc |
DFFN |
0% | 0% |
| DiaMedica Therapeutics Inc |
DMAC |
11% | 3% |
| Dare Bioscience Inc |
DARE |
0% | 0% |
| Cytokinetics Incorporated |
CYTK |
44% | 5% |
| CymaBay Therapeutics Inc |
CBAY |
0% | 0% |
|
|
|
|
| Cyclacel Pharmaceuticals Inc |
CYCCP |
-100% | 18% |
| Cyclacel Pharmaceuticals Inc |
CYCC |
0% | 0% |
| Cumberland Pharmaceuticals Inc |
CPIX |
170% | -6% |
| CTI BioPharma Corp |
CTIC |
0% | 0% |
| Corcept Therapeutics Incorporated |
CORT |
39% | 1% |
| Corbus Pharmaceuticals Holdings Inc |
CRBP |
0% | 0% |
| ContraFect Corporation |
CFRX |
0% | 0% |
| CohBar Inc |
CWBR |
0% | 0% |
| Cocrystal Pharma Inc |
COCP |
-54% | 17% |
| Clovis Oncology Inc |
CLVS |
0% | 0% |
| Citius Pharmaceuticals Inc |
CTXRW |
0% | 0% |
| Citius Pharmaceuticals Inc |
CTXR |
0% | 0% |
| Chimerix Inc |
CMRX |
0% | 5% |
| ChemoCentryx Inc |
CCXI |
0% | 0% |
| Chembio Diagnostics Inc |
CEMI |
0% | 0% |
| Checkpoint Therapeutics Inc |
CKPT |
0% | 14% |
| Centrexion Therapeutics Corporation |
CNTX |
0% | 0% |
| Celsion Corporation |
CLSN |
0% | 0% |
| Cellectar Biosciences Inc |
CLRB |
0% | 16% |
| Catalyst Pharmaceuticals Inc |
CPRX |
47% | 2% |
|
|
|
|
| Catalyst Biosciences Inc |
CBIO |
0% | 0% |
| Capricor Therapeutics Inc |
CAPR |
87% | 13% |
| Bison Capital Acquisition Corp |
BCACU |
0% | 0% |
| Bison Capital Acquisition Corp |
BCAC |
0% | 0% |
| Bio Path Holdings Inc |
BPTH |
0% | 0% |
| BioMarin Pharmaceutical Inc |
BMRN |
-14% | 2% |
| BioLineRx Ltd |
BLRX |
0% | 27% |
| Aytu BioScience Inc |
AYTU |
0% | 0% |
| Avid Bioservices Inc |
CDMO |
0% | -0% |
| AVEO Pharmaceuticals Inc |
AVEO |
0% | 0% |
| Avadel Pharmaceuticals plc |
AVDL |
0% | 0% |
| Aurinia Pharmaceuticals Inc |
AUPH |
80% | -5% |
| Atossa Genetics Inc |
ATOS |
0% | 7% |
| Athersys Inc |
ATHX |
0% | 0% |
| Assertio Therapeutics Inc |
ASRT |
0% | 1% |
| Assembly Biosciences Inc |
ASMB |
0% | 0% |
| Arrowhead Pharmaceuticals Inc |
ARWR |
258% | 5% |
| Array BioPharma Inc |
ARRY |
35% | 11% |
| Arbutus Biopharma Corporation |
ABUS |
31% | 4% |
| Aptevo Therapeutics Inc |
APVO |
0% | 0% |
|
|
|
|
| Apellis Pharmaceuticals Inc |
APLS |
23% | 5% |
| ANI Pharmaceuticals Inc |
ANIP |
41% | 0% |
| Amicus Therapeutics Inc |
FOLD |
54% | 0% |
| Amarin Corporation plc |
AMRN |
0% | 9% |
| Altimmune Inc |
ALT |
-58% | 1% |
| Alpine Immune Sciences Inc |
ALPN |
0% | 0% |
| Alnylam Pharmaceuticals Inc |
ALNY |
26% | -0% |
| Alkermes plc |
ALKS |
45% | 1% |
| Alimera Sciences Inc |
ALIM |
0% | 0% |
| Albireo Pharma Inc |
ALBO |
0% | 0% |
| Akari Therapeutics Plc |
AKTX |
0% | 0% |
| Agios Pharmaceuticals Inc |
AGIO |
-9% | -2% |
| AEterna Zentaris Inc |
AEZS |
0% | 0% |
| Advaxis Inc |
ADXS |
0% | 0% |
| Adamis Pharmaceuticals Corporation |
ADMP |
0% | 0% |
| Achillion Pharmaceuticals Inc |
ACHN |
0% | 0% |
| Acer Therapeutics Inc |
ACER |
0% | 0% |
| AcelRx Pharmaceuticals Inc |
ACRX |
29% | 15% |
| Acasti Pharma Inc |
ACST |
0% | 0% |
| ACADIA Pharmaceuticals Inc |
ACAD |
18% | 0% |
|
|
|
|
| Cue Biopharma Inc. |
CUE |
-48% | 29% |
| Eyenovia Inc. |
EYEN |
0% | -27% |
| Sol-Gel Technologies Ltd. |
SLGL |
6727% | 8% |
| Evolus Inc. |
EOLS |
-43% | 4% |
| BioXcel Therapeutics Inc. |
BTAI |
0% | 7% |
| Arcus Biosciences Inc. |
RCUS |
62% | 1% |
| Homology Medicines Inc. |
FIXX |
0% | 0% |
| Genprex Inc. |
GNPX |
0% | 0% |
| MorphoSys AG |
MOR |
0% | 0% |
| Unity Biotechnology Inc. |
UBX |
0% | 29% |
| ASLAN Pharmaceuticals Limited |
ASLN |
0% | 0% |
| Evelo Biosciences Inc. |
EVLO |
0% | 0% |
| Kiniksa Pharmaceuticals Ltd. |
KNSA |
0% | 0% |
| Iterum Therapeutics plc |
ITRM |
-98% | 9% |
| Verrica Pharmaceuticals Inc. |
VRCA |
0% | 0% |
| Xeris Pharmaceuticals Inc. |
XERS |
67% | 7% |
| Aptinyx Inc. |
APTX |
0% | 0% |
| Kezar Life Sciences Inc. |
KZR |
0% | 0% |
| Magenta Therapeutics Inc. |
MGTA |
0% | 0% |
| Tricida Inc. |
TCDA |
0% | 0% |
|
|
|
|
| Crinetics Pharmaceuticals Inc. |
CRNX |
-33% | 4% |
| Allakos Inc. |
ALLK |
0% | -4% |
| Provention Bio Inc. |
PRVB |
0% | 0% |
| Aquestive Therapeutics Inc. |
AQST |
10% | 0% |
| Adial Pharmaceuticals Inc |
ADIL |
0% | 0% |
| Vaccinex Inc. |
VCNX |
0% | 0% |
| Aridis Pharmaceuticals Inc. |
ARDS |
0% | 0% |
| Elanco Animal Health Incorporated |
ELAN |
98% | -1% |
| Y-mAbs Therapeutics Inc. |
YMAB |
0% | 4% |
| Entasis Therapeutics Holdings Inc. |
ETTX |
0% | 0% |
| Arvinas Inc. |
ARVN |
-56% | 7% |
| Equillium Inc. |
EQ |
301% | 4% |
| PhaseBio Pharmaceuticals Inc. |
PHAS |
0% | 0% |
| Eton Pharmaceutcials Inc. |
ETON |
134% | -2% |
| ObsEva SA |
OBSV |
0% | 0% |
| AnaptysBio Inc. |
ANAB |
264% | 10% |
| BeyondSpring Inc. |
BYSI |
2% | 7% |
| Zymeworks Inc. |
ZYME |
64% | 2% |
| UroGen Pharma Ltd. |
URGN |
137% | 5% |
| Biohaven Pharmaceutical Holding Company Ltd. |
BHVN |
-71% | 3% |
|
|
|
|
| Ovid Therapeutics Inc. |
OVID |
151% | 1% |
| G1 Therapeutics Inc. |
GTHX |
0% | 0% |
| Athenex Inc. |
ATNX |
0% | 0% |
| Avenue Therapeutics Inc. |
ATXI |
0% | 0% |
| Mersana Therapeutics Inc. |
MRSN |
0% | -3% |
| Aileron Therapeutics Inc. |
ALRN |
-54% | 0% |
| Kala Pharmaceuticals Inc. |
KALA |
-99% | 12% |
| Zai Lab Limited |
ZLAB |
-32% | -4% |
| NuCana plc |
NCNA |
0% | 0% |
| Deciphera Pharmaceuticals Inc. |
DCPH |
0% | 0% |
| Rhythm Pharmaceuticals Inc. |
RYTM |
42% | 6% |
| OptiNose Inc. |
OPTN |
0% | 0% |
| Spero Therapeutics Inc. |
SPRO |
156% | 7% |
| scPharmaceuticals Inc. |
SCPH |
0% | 1% |
| BeiGene Ltd. |
BGNE |
60% | -2% |
| Syndax Pharmaceuticals Inc. |
SNDX |
31% | 9% |
| Hutchison China MediTech Limited |
HCM |
-24% | 4% |
| Corvus Pharmaceuticals Inc. |
CRVS |
113% | 9% |
| Aeglea BioTherapeutics Inc. |
AGLE |
0% | 0% |
| Merus N.V. |
MRUS |
0% | 3% |
|
|
|
|
| Reata Pharmaceuticals Inc. |
RETA |
0% | 0% |
| Moleculin Biotech Inc. |
MBRX |
0% | 0% |
| Clearside Biomedical Inc. |
CLSD |
0% | 2% |
| Selecta Biosciences Inc. |
SELB |
0% | 0% |
| Syros Pharmaceuticals Inc. |
SYRS |
0% | 10% |
| Protagonist Therapeutics Inc. |
PTGX |
164% | -1% |
| Novan Inc. |
NOVN |
0% | 0% |
| AC Immune SA |
ACIU |
-11% | 10% |
| Myovant Sciences Ltd. |
MYOV |
0% | 0% |
| Ascendis Pharma A/S |
ASND |
74% | 2% |
| Bellerophon Therapeutics Inc. |
BLPH |
0% | 0% |
| Summit Therapeutics plc |
SMMT |
-4% | 2% |
| XBiotech Inc. |
XBIT |
-46% | 12% |
| KemPharm Inc. |
KMPH |
35% | 3% |
| Viking Therapeutics Inc. |
VKTX |
-27% | 7% |
| Blueprint Medicines Corporation |
BPMC |
0% | 1% |
| Collegium Pharmaceutical Inc. |
COLL |
8% | 3% |
| Jaguar Health Inc. |
JAGX |
0% | 0% |
| Galapagos NV |
GLPG |
-0% | 3% |
| Celyad SA |
CYAD |
0% | 0% |
|
|
|
|
| Seres Therapeutics Inc. |
MCRB |
0% | 7% |
| vTv Therapeutics Inc. |
VTVT |
0% | 0% |
| Zynerba Pharmaceuticals Inc. |
ZYNE |
0% | 0% |
| Global Blood Therapeutics Inc. |
GBT |
0% | 0% |
| Benitec Biopharma Limited |
BNTC |
0% | 0% |
| Nabriva Therapeutics plc |
NBRV |
0% | 0% |
| Aclaris Therapeutics Inc. |
ACRS |
67% | 4% |
| CytomX Therapeutics Inc. |
CTMX |
180% | 11% |
| Kura Oncology Inc. |
KURA |
3% | 0% |
| WAVE Life Sciences Ltd. |
WVE |
-54% | 9% |
| Axsome Therapeutics Inc. |
AXSM |
171% | 2% |
| GlycoMimetics Inc. |
GLYC |
0% | 9% |
| Trevena Inc. |
TRVN |
0% | 0% |
| Ultragenyx Pharmaceutical Inc. |
RARE |
-47% | -1% |
| Cara Therapeutics Inc. |
CARA |
0% | 0% |
| uniQure N.V. |
QURE |
59% | 2% |
| Revance Therapeutics Inc. |
RVNC |
0% | 1% |
| Eagle Pharmaceuticals Inc. |
EGRX |
0% | 0% |
| Concert Pharmaceuticals Inc. |
CNCE |
0% | 0% |
| Galmed Pharmaceuticals Ltd. |
GLMD |
-77% | 9% |
|
|
|
|
| Akebia Therapeutics Inc. |
AKBA |
-47% | 0% |
| Aravive Inc. |
ARAV |
0% | 0% |
| Phibro Animal Health Corporation |
PAHC |
46% | -2% |
| Aldeyra Therapeutics Inc. |
ALDX |
-68% | 9% |
| SCYNEXIS Inc. |
SCYX |
-48% | 17% |
| Agile Therapeutics Inc. |
AGRX |
0% | 0% |
| Radius Health Inc. |
RDUS |
0% | 0% |
| Ardelyx Inc. |
ARDX |
15% | -2% |
| Amphastar Pharmaceuticals Inc. |
AMPH |
-49% | -2% |
| Minerva Neurosciences Inc |
NERV |
119% | 3% |
| Sage Therapeutics Inc. |
SAGE |
0% | 13% |
| Ocular Therapeutix Inc. |
OCUL |
2% | 3% |
| Marinus Pharmaceuticals Inc. |
MRNS |
0% | 1% |
| Catalent Inc. |
CTLT |
0% | 0% |
| Otonomy Inc. |
OTIC |
0% | 0% |
| Affimed N.V. |
AFMD |
0% | 0% |
| ProQR Therapeutics N.V. |
PRQR |
-46% | 4% |
| Vascular Biogenics Ltd. |
VBLT |
0% | 0% |
| Calithera Biosciences Inc. |
CALA |
0% | 0% |
| Journey Medical Corporation |
DERM |
48% | 9% |
|
|
|
|
| Forward Pharma A/S |
FWP |
0% | 0% |
| Xenon Pharmaceuticals Inc. |
XENE |
29% | 3% |
| FibroGen Inc |
FGEN |
0% | 3% |
| Bellicum Pharmaceuticals Inc. |
BLCM |
0% | 0% |
